Health Care: Drugs

Bristol-Myers Squibb Company (BMY: NYSE)

$58.75 -0.86 | -1.44%
09/03/15 - 04:01 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 15.88B 16.38B 17.62B 21.24B
Cost of Sales 3.46B 3.86B 3.93B 4.80B
Gross Operating Profit 12.41B 12.53B 13.69B 16.45B
Selling, General, and Administrative Expenses 4.09B 4.08B 4.22B 4.20B
Research & Development 4.53B 3.73B 3.90B 3.84B
Operating Income before D & A (EBITDA) 3.06B 3.86B 4.77B 7.45B
Depreciation & Amortization 467.00M 763.00M 681.00M 801.00M
Interest Income 0.00 0.00 0.00 91.00M
Other Income - Net -114.00M -172.00M 79.00M 504.00M
Special Income / Charges 0.00 0.00 -1.83B 0.00
Total Income Before Interest Expenses (EBIT) 2.58B 3.09B 2.52B 7.13B
Interest Expense 203.00M 199.00M 182.00M 145.00M
Pre-Tax Income 2.38B 2.89B 2.34B 6.98B
Income Taxes 352.00M 311.00M -161.00M 1.72B
Minority Interest 25.00M 17.00M 541.00M 1.55B
Net Income From Continuing Operations 2.03B 2.58B 2.50B 5.26B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 2.03B 2.58B 2.50B 5.26B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 2.00B 2.56B 1.96B 3.71B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.03B 2.58B 4.33B 5.38B
Preferred Dividends
Net Income Available To Common 2.03B 2.58B 2.50B 5.26B
Basic EPS from Continuing Ops. 1.21 1.56 1.17 2.18
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.21 1.56 1.17 2.18
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.21 1.56 1.17 2.18
Basic Normalized Net Income/Share 1.21 1.56 2.03 2.23
EPS fr Continuing Ops. 1.20 1.54 1.16 2.16
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.20 1.54 1.16 2.16
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.20 1.54 1.16 2.16
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.20 1.54 2.01 2.21
Dividends Paid per Share 1.45 1.76 1.36 1.32

Portfolios with BMY

Latest BMY Headlines from TheStreet

More Financial News for BMY

Press Releases for BMY

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter